Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$330,302,659
+$104,408,067 QoQ
Shares Held
275,383
+12.1% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#199
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $677,640,956 across 15 Drug Manufacturers - General names. LLY ranks #1 (48.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
275,383 | $330,302,659 | |
| 2 | JNJ |
Johnson & Johnson
|
953,567 | $242,177,410 | |
| 3 | MRK |
Merck & Co., Inc.
|
257,653 | $33,108,410 | |
| 4 | ABBV |
AbbVie Inc.
|
127,844 | $32,170,664 | |
| 5 | AMGN |
Amgen Inc
|
29,505 | $10,684,350 | |
| 6 | NVS |
Novartis AG
|
50,794 | $7,960,435 | |
| 7 | PFE |
Pfizer Inc
|
327,905 | $7,895,952 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
97,895 | $5,640,709 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $330,302,659 | 275,383 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $225,894,592 | 245,599 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $197,956,074 | 184,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $138,752,313 | 181,851 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $141,144,819 | 181,064 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $98,149,492 | 118,838 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,348,376 | 26,358 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $19,196,547 | 21,668 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,894,390 | 18,660 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $12,494,815 | 16,061 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $9,952,776 | 17,074 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,127,987 | 16,994 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,603,572 | 16,213 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $5,501,588 | 16,020 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,897,706 | 16,121 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,311,347 | 16,426 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,410,426 | 16,687 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,793,551 | 20,231 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,404,327 | 15,945 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,523,512 | 15,250 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,489,622 | 15,204 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,403,299 | 18,217 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,124,890 | 18,508 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,776,559 | 18,758 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,091,181 | 18,828 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,642,893 | 19,052 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||